Mitomycin-C Kyowa 10 mg, Powder for Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

mitomycin-c kyowa 10 mg, powder for solution for injection

kyowa kirin holdings b.v. - mitomycin - powder for solution for injection - 10 milligram(s) - other cytotoxic antibiotics; mitomycin

Mitomycin-C Kyowa 40 mg, powder for intravesical solution Ireland - English - HPRA (Health Products Regulatory Authority)

mitomycin-c kyowa 40 mg, powder for intravesical solution

kyowa kirin holdings b.v. - mitomycin - powder for solution for infusion - 40 milligram(s) - other cytotoxic antibiotics; mitomycin

Xomolix 2.5 mg/ml solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

xomolix 2.5 mg/ml solution for injection

kyowa kirin holdings b.v. - droperidol - solution for injection - 2.5 milligram(s)/millilitre - butyrophenone derivatives; droperidol

Chlorphenamine 10 mg/ml Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

chlorphenamine 10 mg/ml solution for injection

kyowa kirin holdings b.v. - chlorphenamine maleate - solution for injection - 10 milligram(s)/millilitre - substituted alkylamines; chlorphenamine

Pabrinex Intravenous High Potency Concentrate for Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

pabrinex intravenous high potency concentrate for solution for infusion

kyowa kirin holdings b.v. - ascorbic acid; riboflavine; pyridoxine hydrochloride ; nicotinamide; thiamine hydrochloride; glucose (as monohydrate) - concentrate for solution for infusion - . - vitamin b-complex with vitamin c

Rectogesic 4 mg/g Rectal Ointment Ireland - English - HPRA (Health Products Regulatory Authority)

rectogesic 4 mg/g rectal ointment

kyowa kirin holdings b.v. - glyceryl trinitrate - rectal ointment - 4 milligram(s)/gram - muscle relaxants; glyceryl trinitrate

Xomolix 0.5 mg/ml Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

xomolix 0.5 mg/ml solution for injection

kyowa kirin holdings b.v. - droperidol - solution for injection - 0.5 milligram(s)/millilitre - butyrophenone derivatives; droperidol

Tostran 2% Gel Ireland - English - HPRA (Health Products Regulatory Authority)

tostran 2% gel

kyowa kirin holdings b.v. - testosterone - gel - 2 percent weight/weight - 3-oxoandrosten (4) derivatives; testosterone

Crysvita European Union - English - EMA (European Medicines Agency)

crysvita

kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - drugs for treatment of bone diseases - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults.crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.

Moventig European Union - English - EMA (European Medicines Agency)

moventig

kyowa kirin holdings b.v. - naloxegol oxalate - constipation; opioid-related disorders - peripheral opioid receptor antagonists, drugs for constipation - treatment of opioid-induced constipation (oic) in adult patients who have had an inadequate response to laxative(s).